Form D · Biotechnology
Phantom Neuro Inc.
Austin, TX · CIK 0001919709
Offering snapshot reported Mar 18, 2025 · SEC filing
- Reported sold
- $12.1M Offering amount: $19.3M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2025 | Initial | $12,097,140 | No comparison | 22 | SEC filing |
| Mar 25, 2022 | Initial | $3,259,998 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-541184
Source: Form D, filed Mar 18, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Connor Glass | Director, Executive, Promoter |
| Robert Lord | Director |
| Edward Michael | Director |
| D.A. Wallach | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
507 South Park Drive, Unit 1
Austin, TX, 78704
Austin, TX, 78704